Skip to content
‹ Back to IndustriesHealthcare

Physicians Footcare and CurveBeam Mobile Hit the Road

CurveBeam Mobile makes weight-bearing CT imaging accessible and affordable to all providers, regardless of practice size. Featuring custom-built mobile imaging suites and expertly trained technicians, CurveBeam Mobile delivers the ultimate in cost-effective service and convenience, providing a first-class experience for patients and unparalleled diagnostic support for practices. Recently, Physicians Footcare (PFC), a full-service podiatry practice…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Try it Free

CurveBeam Mobile makes weight-bearing CT imaging accessible and affordable to all providers, regardless of practice size. Featuring custom-built mobile imaging suites and expertly trained technicians, CurveBeam Mobile delivers the ultimate in cost-effective service and convenience, providing a first-class experience for patients and unparalleled diagnostic support for practices.

A patient is ready for a standing CT scan in Physicians Footcare’s mobile imaging facility.

Recently, Physicians Footcare (PFC), a full-service podiatry practice with 11 offices located throughout South Carolina, announced it will begin providing standing CT services to its locations via a mobile imaging center, which was custom built by CurveBeam Mobile.

The state-of-the-art mobile imaging facility is the first-of-its-kind in the United States. The imaging facility will travel around Richland and Aiken counties to each PFC location, scanning patients in communities throughout the Palmetto state.

“Our unique delivery model provides our patients with the quality and sophistication of care they would expect from the very best medical centers in the country,” said Dr. Kevin L. Ray. “This motto provides our patients with the convenience and comfort of personalized care they receive from the local practitioner they know and trust.”

Until standing CT technology was introduced in the United States in 2012, foot and ankle physicians and radiologists had to rely on conventional medical CT, in which a patient is scanned while lying down.

However, the American Orthopedic Foot & Ankle Society recommends standing imaging when possible. Imaging patients while they are standing provides a true assessment of bone and joint alignment. Standing CT scans will allow the PFC’s 15 podiatric physicians to diagnose and treat conditions including but not limited to fractures, subluxations and dislocations, midfoot injuries, bunions, flat feet, sprains, arthritis, and diabetic-related complications.

The mobile imaging suite is outfitted with a CurveBeam pedCAT. The CurveBeam pedCAT takes 360 two-dimensional X-Rays of each foot and stitches them together to create an exact, three-dimensional digital replica of the foot and ankle, allowing PFC physicians a comprehensive study of each foot and ankle structure.

A pedCAT standing CT scan takes less than 45 seconds, and radiation dose is lower than a conventional medical CT exam.

Both CurveBeam Mobile and PFC are excited about this first of its kind venture.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512